We are live on ! Find out more
SMMT icon

Summit Therapeutics
SMMT

45 hedge funds and large institutions have $2.88M invested in Summit Therapeutics in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 5 increasing their positions, 16 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.59% less ownership

Funds ownership: 11.23% → 8.64% (-2.6%)

13% less funds holding

Funds holding: 52 → 45 (-7)

30% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 20

69% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 16

75% less capital invested

Capital invested by funds: $11.7M → $2.88M (-$8.81M)

Holders
45
Holders Change
-7
Holders Change %
-13.46%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
5
Reduced
16
Closed
20
Calls
$57K
Puts
–
Net Calls
+$57K
Net Calls Change
+$24K

Top Buyers

1
Millennium Management
Millennium Management
New York
+$641K
2
AGM
Alpine Global Management
New York
+$421K
3
E
Ergoteles
New York
+$141K
4
Citadel Advisors
Citadel Advisors
Florida
+$79.5K
5
Renaissance Technologies
Renaissance Technologies
New York
+$68.9K

Top Sellers

1
BlackRock
BlackRock
New York
-$1.49M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$1.07M
3
PCH
Polar Capital Holdings
United Kingdom
-$944K
4
State Street
State Street
Massachusetts
-$768K
5
Northern Trust
Northern Trust
Illinois
-$431K
Name Holding Trade Value Shares
Change 		Change in
Stake
YIH
26
Y-Intercept (HK)
Hong Kong
$10K +$14.5K +10,355 New
TRCT
27
Tower Research Capital (TRC)
New York
$9K +$7.27K +5,187 +124%
JP Morgan Chase
28
JP Morgan Chase
New York
$6K -$26.4K -18,849 -79%
PCH
29
Polar Capital Holdings
United Kingdom
$5.6K -$944K -673,102 -11%
EW
30
Evoke Wealth
California
$5K +$7.01K +5,000 New
ATC
31
Adirondack Trust Company
New York
$3K – – –
National Bank of Canada
32
National Bank of Canada
Quebec, Canada
$3K – – –
Citigroup
33
Citigroup
New York
$2K -$2.2K -1,570 -48%
TCWA
34
Ten Capital Wealth Advisors
Washington
$2K – – –
Barclays
35
Barclays
United Kingdom
$1K -$4.53K -3,233 -74%
WAM
36
Worth Asset Management
Texas
$1K – – –
HI
37
Harbour Investments
Wisconsin
$1K +$1.82K +1,300 New
Baillie Gifford & Co
38
Baillie Gifford & Co
United Kingdom
– -$1.07M -436,512 Closed
State Street
39
State Street
Massachusetts
– -$768K -313,401 Closed
Northern Trust
40
Northern Trust
Illinois
– -$431K -175,682 Closed
Charles Schwab
41
Charles Schwab
California
– -$151K -61,313 Closed
N
42
Nuveen
North Carolina
– -$178K -54,748 Closed
Bank of New York Mellon
43
Bank of New York Mellon
New York
– -$122K -49,763 Closed
Allspring Global Investments
44
Allspring Global Investments
North Carolina
– -$83K -33,915 Closed
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
– -$37K -15,115 Closed
ProShare Advisors
46
ProShare Advisors
Maryland
– -$37K -15,054 Closed
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
– -$20.5K -14,600 -99%
Deutsche Bank
48
Deutsche Bank
Germany
– -$35K -14,310 Closed
AIG
49
American International Group
New York
– -$32K -13,087 Closed
Invesco
50
Invesco
Georgia
– -$28K -11,273 Closed
1
2
3

SMMT Hedge Fund Activity: Q2 2022 in Review

45 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Summit Therapeutics (SMMT) for Q2 2022, worth a combined $2.88M — down 75% from $11.7M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of SMMT and 14 opened new positions — a net loss of 6 holders — while 16 trimmed existing stakes and 5 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $641K. The largest seller was BlackRock, cutting an estimated $1.49M.

  • 45 institutional investors held Summit Therapeutics (SMMT) as of Q2 2022, down from 52 in Q1 2022.
  • Funds reported $2.88M of Summit Therapeutics stock for Q2 2022, down 75% quarter-over-quarter.
  • 14 funds opened new Summit Therapeutics positions in Q2 2022 and 20 closed out, a net change of -6 holders.
  • The largest Summit Therapeutics buyer in Q2 2022 was Millennium Management, an estimated $641K added.
  • The largest Summit Therapeutics seller in Q2 2022 was BlackRock, an estimated $1.49M sold.

Based on aggregated 13F filings for Q2 2022.